I’m as unhappy as the next guy. My dream/hope of GMV making us all rich is quick diminishing. The lack of clarity is difficult to get my head around. It looks like the India deal is dead and MEDTL has taken the prisma off the site. I have emailed MEDTL about it. I’ll advise if I receive response. The patch FDA appears to have been pushed to next year.
The positives we expect next 8 wks:- 1.Listing on Nasdaq. Oversubscribed will push price up. The 25 m will take the financial pressures off the company. 2.CFDA will unlock China. If China’s MOUS are worthless then why try to list on HKSE?. I feel this mou is the mostly likely to occur. 3. A deal in UK will be on the cards.
HKSE will happen I feel early next year. If we get that far GMV will most likely be much higher.
GLTA and GO GMV !!!
GMV Price at posting:
23.0¢ Sentiment: Buy Disclosure: Held
